ANTIGEN EXPRESS, INC.

Address

ANTIGEN EXPRESS, INC.
100 BARBER AVE
WORCESTER, MA, 01606

Information

DUNS:
# of Employees: N/A

Ownership Information

Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N

Award Charts




Award Listing

  1. li Suppression-enhanced HIV DNA Vaccine

    Amount: $354,100.00

    DESCRIPTION (provided by applicant): Antigen Express scientists have discovered that cells expressing MHC class II molecules in the absence of the MHC class II-associated Ii protein can act as effecti ...

    SBIRPhase I2003Department of Health and Human Services
  2. HER-2/neu T Helper/Memory Vaccine for Breast Cancer

    Amount: $224,700.00

    DESCRIPTION (provided by applicant): Antigen Express scientists have demonstrated that the li-Key segment of the li protein, acting at an allosteric site of Class II molecules, facilitates charging b ...

    SBIRPhase I2003Department of Health and Human Services
  3. li-Key/Melanoma MHC Class II Vaccines

    Amount: $444,070.00

    DESCRIPTION (provided by applicant): MHC-presented peptide vaccines are one of the most promising experimental therapies for melanoma. However, MHC class I peptides that prime CTLs lack dramatic anti- ...

    SBIRPhase I2003Department of Health and Human Services
  4. HIV LI-KEY/PEPTIDE VACCINE

    Amount: $301,761.00

    Antigen Express scientists have discovered that a segment of the Ii protein called Ii-Key, which acts at an allosteric site on one end of the antigenic peptide binding site on MHC Class II molecules, ...

    SBIRPhase I2002Department of Health and Human Services
  5. PROSTATE CANCER VACCINE BY SUPPRESSING Ii PROTEIN

    Amount: $191,744.00

    DESCRIPTION: Suppressing the Ii protein by anti-sense oligonucleotides in MHC class Il-positive cancer cells creates a potent cancer cell vaccine. Presumably, additional determi ...

    SBIRPhase I2001Department of Health and Human Services
  6. COMBINED IL-2 AND MHC CLASS II GENE THERAPY FOR CANCER

    Amount: $287,382.00

    DESCRIPTION: Antigen Express has developed technology to force the presentation of endogenous tumor antigens in a manner that produces an effective tumor cell vaccine. The key to this strat ...

    SBIRPhase I2001Department of Health and Human Services
  7. N/A

    Amount: $173,340.00

    N/A

    SBIRPhase I2000Department of Health and Human Services
  8. IMPROVING DNA VACCINES FOR HIV1

    Amount: $100,000.00

    N/A

    SBIRPhase I1998Department of Health and Human Services
  9. IIKEY PEPTIDE THERAPEUTICS

    Amount: $100,000.00

    A new class of immunotherapeutic drugs will be designed around the IiKEY peptide to enhance or inhibit, in an MHC class II allele related manner, immune responses in several disease states. Binding o ...

    SBIRPhase I1997Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government